Search research articles
Contact Us
Filters
Showing results (101-110 of 140) with videos related to
Page
of 14
Sort By:
The American Journal of Psychiatry
|
April 17, 2009
Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study
Ling Zheng, Wendy J Mack, Karen S Dagerman, et al.
JMIR Mental Health
|
February 14, 2025
Telehealth-Based vs In-Person Aerobic Exercise in Individuals With Schizophrenia: Comparative Analysis of Feasibility, Safety, and Efficacy
David Kimhy, Luz H Ospina, Melanie Wall, et al.
Schizophrenia Research
|
May 13, 2011
Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE study
T Scott Stroup, Paul S Appelbaum, Hongbin Gu, et al.
Schizophrenia Research
|
June 7, 2008
Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1
Jonathan M Meyer, Vicki G Davis, Joseph P McEvoy, et al.
Schizophrenia Research
|
September 9, 2008
Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study
Gail L Daumit, Donald C Goff, Jonathan M Meyer, et al.
The American Journal of Psychiatry
|
March 3, 2007
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study
T Scott Stroup, Jeffrey A Lieberman, Joseph P McEvoy, et al.
The American Journal of Psychiatry
|
April 6, 2006
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic
T Scott Stroup, Jeffrey A Lieberman, Joseph P McEvoy, et al.
Journal of Affective Disorders
|
August 27, 2024
Clinical characteristics and functioning of adults with bipolar I disorder: Evidence from the mental and substance use disorders prevalence study
Natalie Bareis, Mark Olfson, Lisa B Dixon, et al.
PLOS Mental Health
|
September 2, 2025
Impact of insurance type on outpatient mental health treatment of US adults
Lydia A Chwastiak, Scott Graupensperger, Heather Ringeisen, et al.
Schizophrenia Research
|
September 21, 2005
Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial
Del D Miller, Joseph P McEvoy, Sonia M Davis, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 140) with videos related to
Sort By:
Page
of 14
The American Journal of Psychiatry
|
April 17, 2009
Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study
Ling Zheng, Wendy J Mack, Karen S Dagerman, et al.
JMIR Mental Health
|
February 14, 2025
Telehealth-Based vs In-Person Aerobic Exercise in Individuals With Schizophrenia: Comparative Analysis of Feasibility, Safety, and Efficacy
David Kimhy, Luz H Ospina, Melanie Wall, et al.
Schizophrenia Research
|
May 13, 2011
Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE study
T Scott Stroup, Paul S Appelbaum, Hongbin Gu, et al.
Schizophrenia Research
|
June 7, 2008
Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1
Jonathan M Meyer, Vicki G Davis, Joseph P McEvoy, et al.
Schizophrenia Research
|
September 9, 2008
Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study
Gail L Daumit, Donald C Goff, Jonathan M Meyer, et al.
The American Journal of Psychiatry
|
March 3, 2007
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study
T Scott Stroup, Jeffrey A Lieberman, Joseph P McEvoy, et al.
The American Journal of Psychiatry
|
April 6, 2006
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic
T Scott Stroup, Jeffrey A Lieberman, Joseph P McEvoy, et al.
Journal of Affective Disorders
|
August 27, 2024
Clinical characteristics and functioning of adults with bipolar I disorder: Evidence from the mental and substance use disorders prevalence study
Natalie Bareis, Mark Olfson, Lisa B Dixon, et al.
PLOS Mental Health
|
September 2, 2025
Impact of insurance type on outpatient mental health treatment of US adults
Lydia A Chwastiak, Scott Graupensperger, Heather Ringeisen, et al.
Schizophrenia Research
|
September 21, 2005
Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial
Del D Miller, Joseph P McEvoy, Sonia M Davis, et al.
Page
of 14